Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
James Heyes

James Heyes

Chief Executive Officer, Genevant Sciences

Appears in 1 story

Notable Quotes

"The settlement allows us to put this lengthy dispute behind us. At the same time, it is enormously gratifying for the Genevant team to, at long last, be recognized for our pivotal contribution to restoring normalcy around the world in the face of a once-in-a-lifetime pandemic." — Statement on March 3, 2026

Stories

Moderna's battle over the delivery technology in its COVID vaccine

Rule Changes

Settlement reached

For four years, Moderna faced questions about whether it owed billions for technology at the heart of its COVID-19 vaccine. Less than a week before a jury trial in Delaware, Moderna agreed to pay $2.25 billion to settle patent claims from Arbutus Biopharma and Genevant Sciences. The court found it infringed four valid patents, and if paid in full, it would be the largest disclosed patent settlement in pharmaceutical history, surpassing a $2.15 billion Pfizer-Takeda settlement in 2013.

Updated May 30